Inventor · disambiguated record
Marta Nevalainen
Also filed as: NEVALAINEN MARTA
14 granted patents·10 pending applications·231 citations·filing 2005–2025
91Inventor score
Files withBIOGEN MA INC9INFINITY PHARMACEUTICALS INC4EISAI R&D MAN CO LTD3INFINITY DISCOVERY INC3BAHADOOR ADILAH2
Top patents by PatentIndex Score
24 records- 0197US7230004B2Cyclopamine analogues and methods of use thereofINFINITY DISCOVERY INC·Filed 2005·Granted Jun 12, 2007·104 cites·39 claims
- 0296US7407967B2Cyclopamine analogues and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2007·Granted Aug 5, 2008·52 cites·18 claims
- 0395US7875628B2Cyclopamine analogues and methods of use thereofINFINITY DISCOVERY INC·Filed 2008·Granted Jan 25, 2011·41 cites·41 claims
- 0492US8236956B2Cyclopamine analogues and methods of use thereofADAMS JULIAN·Filed 2010·Granted Aug 7, 2012·21 cites·15 claims
- 0581US8546432B2Tetrazolones as inhibitors of fatty acid synthaseBAHADOOR ADILAH·Filed 2011·Granted Oct 1, 2013·7 cites·35 claims
- 0680US12391697B2Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2020·Granted Aug 19, 2025·1 cites·20 claims
- 0775US9346769B2Tetrazolones as inhibitors of fatty acid synthaseINFINITY PHARMACEUTICALS INC·Filed 2013·Granted May 24, 2016·2 cites·57 claims
- 0874US2024368140A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 0973US10899753B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2019·Granted Jan 26, 2021·1 cites·20 claims
- 1072US11926619B2Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 12, 2024·1 cites·18 claims
- 1167US2025333400A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2025·Application pending·0 cites
- 1266US8450350B2Triazoles as inhibitors of fatty acid synthaseBAHADOOR ADILAH·Filed 2011·Granted May 28, 2013·1 cites·37 claims
- 1360US2025304577A1Tyk2 inhibitorsBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 1459US7928244B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY DISCOVERY INC·Filed 2007·Granted Apr 19, 2011·0 cites·37 claims
- 1557US2025034150A1Btk inhibitorsBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 1657US2025090524A1Btk inhibitorsBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 1756US8178690B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2011·Granted May 15, 2012·0 cites·15 claims
- 1856US2024287076A1Compounds for targeting degradation of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 1954US8609706B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2012·Granted Dec 17, 2013·0 cites·14 claims
- 2052US2024083900A1Pyrazolo[1,5-a]pyrazine derivatives as btk inhibitorsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 2152US2024327380A1Btk inhibitorsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 2249US12240838B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2020·Granted Mar 4, 2025·0 cites·21 claims
- 2349US2013243727A1Triazoles as inhibitors of fatty acid synthaseINFINITY PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2449US2017119734A1Tetrazolones as inhibitors of fatty acid synthaseINFINITY PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marta Nevalainen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →